
|Videos|September 18, 2015
Which Medications Will Be Growth Drivers in the Industry in the Next Few Years?
Doug Long, vice president of industry relations at IMS Health, talks about which approved or pipeline drugs will be growth drivers in the industry during the next few years.
Advertisement
Doug Long, vice president of industry relations at IMS Health, talks about which approved or pipeline drugs will be growth drivers in the industry during the next few years.
This video was recorded at the 2015 NACDS Total Store Expo.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Etuvetidigene Autotemcel, First Gene Therapy for Wiskott-Aldrich Syndrome
2
Advancing Treatment After CDK4/6 Inhibitor Progression in HR+/HER2– Breast Cancer
3
Opinion: To Succeed, Direct-to-Patient Drug Sales Will Require Better Technology
4
How Next-Generation CDK Inhibitors Are Redefining Post–CDK4/6 Therapy in HR+/HER2– Metastatic Breast Cancer
5


















































































































































































































